Syros Pharmaceuticals Inc. (NASDAQ: SYRS)
$0.2105
+0.0005 ( -0.47% ) 1.3M
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Market Data
Open
$0.2105
Previous close
$0.2100
Volume
1.3M
Market cap
$5.42M
Day range
$0.1980 - $0.2210
52 week range
$0.1830 - $7.9600
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| pre | Proxies and info statements | 7 | Apr 12, 2024 |
| 4 | Insider transactions | 1 | Apr 05, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Apr 02, 2024 |
| 10-k | Annual reports | 116 | Mar 27, 2024 |
| 8-k | 8K-related | 32 | Jan 08, 2024 |